Reading Time: 3 minutes Pharmaceutical company AbbVie has blocked competitors from entering the market for its blockbuster drug Humira through legal exploitation of the US patent system. This has allowed AbbVie to increase the price of Humira, the most lucrative franchise in pharmaceutical history, over the past six years and generate $114 billion in revenue since 2016. The knockoff […]
Source: How a Drug Company Made $114 Billion by Gaming the U.S. Patent System